S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
NASDAQ:ATRI

Atrion Stock Forecast, Price & News

$717.00
+6.85 (+0.96 %)
(As of 10/22/2021 04:00 PM ET)
Add
Compare
Today's Range
$707.24
$717.00
50-Day Range
$627.20
$758.00
52-Week Range
$567.00
$783.84
Volume2,219 shs
Average Volume7,012 shs
Market Capitalization$1.31 billion
P/E Ratio42.00
Dividend Yield1.16%
Beta0.08
30 days | 90 days | 365 days | Advanced Chart
Receive ATRI News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.


Atrion logo

About Atrion

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products fro cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing & kitting services; and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
Employees
636
Year Founded
N/A

Sales & Book Value

Annual Sales
$147.59 million
Cash Flow
$22.32 per share
Book Value
$129.63 per share

Profitability

Net Income
$32.12 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.31 billion
Next Earnings Date
11/8/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.97 out of 5 stars

Medical Sector

619th out of 1,359 stocks

Surgical & Medical Instruments Industry

64th out of 124 stocks

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












Atrion (NASDAQ:ATRI) Frequently Asked Questions

What stocks does MarketBeat like better than Atrion?

Wall Street analysts have given Atrion a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Atrion wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Atrion's next earnings date?

Atrion is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Atrion
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings results on Monday, August, 9th. The medical instruments supplier reported $4.88 earnings per share (EPS) for the quarter. The medical instruments supplier earned $42.69 million during the quarter. Atrion had a net margin of 21.14% and a trailing twelve-month return on equity of 12.97%.
View Atrion's earnings history
.

How has Atrion's stock been impacted by Coronavirus (COVID-19)?

Atrion's stock was trading at $667.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ATRI stock has increased by 7.5% and is now trading at $717.00.
View which stocks have been most impacted by COVID-19
.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Monday, August 30th. Investors of record on Wednesday, September 15th will be paid a dividend of $1.95 per share on Thursday, September 30th. This represents a $7.80 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date of this dividend is Tuesday, September 14th. This is an increase from Atrion's previous quarterly dividend of $1.75.
View Atrion's dividend history
.

Is Atrion a good dividend stock?

Atrion pays an annual dividend of $7.80 per share and currently has a dividend yield of 1.16%.
View Atrion's dividend history.

Who are Atrion's key executives?

Atrion's management team includes the following people:
  • David A. Battat, President & Chief Executive Officer
  • Jeffery Strickland, Chief Financial Officer, Secretary, Treasurer & VP

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion CEO David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among Atrion's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

Who are Atrion's major shareholders?

Atrion's stock is owned by a number of retail and institutional investors. Top institutional investors include Harbor Investment Advisory LLC (0.01%) and Nisa Investment Advisors LLC (0.00%). Company insiders that own Atrion stock include Emile A Battat and John P Stupp Jr.
View institutional ownership trends for Atrion
.

Which institutional investors are selling Atrion stock?

ATRI stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC.
View insider buying and selling activity for Atrion
or view top insider-selling stocks.

Which institutional investors are buying Atrion stock?

ATRI stock was purchased by a variety of institutional investors in the last quarter, including Harbor Investment Advisory LLC.
View insider buying and selling activity for Atrion
or or view top insider-buying stocks.

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $717.00.

How much money does Atrion make?

Atrion has a market capitalization of $1.31 billion and generates $147.59 million in revenue each year.

How many employees does Atrion have?

Atrion employs 636 workers across the globe.

What is Atrion's official website?

The official website for Atrion is www.atrioncorp.com.

Where are Atrion's headquarters?

Atrion is headquartered at ONE ALLENTOWN PARKWAY, ALLEN TX, 75002.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at (972) 390-9800 or via email at [email protected].


This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.